Ion Beam Applications S.A. (IBAB.BR) Stock Analysis & Winston Score

Ion Beam Applications (IBA) is a Belgian company that builds particle accelerators used mainly in two areas: cancer treatment and industrial applications. Its proton therapy systems deliver precise radiation to tumors while minimizing damage to surrounding healthy tissue, serving hospitals and cancer centers worldwide. IBA also makes cyclotrons that produce radioactive materials used in medical imaging and supplies dosimetry equipment that measures radiation doses. The company earns revenue from equipment sales, long-term service contracts, and the sale of radiopharmaceutical production systems. IBA operates globally with installations across Europe, the Americas, and Asia, and it holds a leading market share in proton therapy systems. Its installed base of machines creates recurring service revenue, which provides some earnings stability. Growth depends on broader hospital adoption of proton therapy, but the technology remains expensive, and reimbursement uncertainty in key markets poses an ongoing risk to order momentum.